QL1706 Plus Chemotherapy for Borderline Resectable Esophageal Cancer

Clinical trial NCT07283991 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07283991
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2025-12-30
Primary completion: 2026-08-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.